Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Allright ladies and gents. We have 10 minutes left. Can we break .004?
Good stuff.
2 hours in. Still have 4 and a half left. As well as the rest of the week + more.
Correct. I have to use my mobile Web app. Are you having the same issues?
Anyone having issues on the mobile app in regards to board messages?
For New/Current Investors
***Apologies for the re-post. Since markets are about to open, I wanted this closer to the top so potential new investor's know where to go and what to read up on****
New/Current Investors, please review sticky post #9538. With the help of everyone on this board, it contains a consolidated review, supplemental information and DD on TRON's recent MERGER Press Release with iMed.
TRON is in the process of completing an APO (Alternate Public Offer) which is similar to an IPO, except faster, easier and with private backing.
Links to what an APO is along with examples are contained within sticky post #9538. Other members have also provided details, examples and explanations with their individual post's.
I Highly encourage any new investor's that are interested in TRON to take a look. Also, please review TRON's latest 15-C as well.
http://www.otcmarkets.com/financialReportViewer?symbol=TRON&id=158205
THERE IS a reverse split announced within the 15-C. As investor's on this board explained, IT'S A RECAPITALIZATION OF THE COMPANY'S STOCK for the APO. I do not recommend reviewing the term "REVERSE SPLIT" as an actual R/S, or as a negative. TRON has announced ample information regarding it's merger and the road-map of TRON's future. HOKIEHEAD has made numerous post's explaining how the R/S is in fact a recapitalization.
Again, sticky #9538 explains in detail the Press Release and ample supplemental information regarding TRON's merger and APO.
If any investor has questions, please feel free to ask anyone on this board. I would like this board to be as healthy and helpful as possible.
Well put. Let's hope investors digested the PR over the weekend and ready to join the team.
New/Current Investors, please review sticky post #9538. With the help of everyone on this board, it contains a consolidated review, supplemental information and DD on TRON's recent MERGER Press Release with iMed.
TRON is in the process of completing an APO (Alternate Public Offer) which is similar to an IPO, except faster, easier and with private backing.
Links to what an APO is along with examples are contained within sticky post #9538. Other members have also provided details, examples and explanations with their individual post's.
I Highly encourage any new investor's that are interested in TRON to take a look. Also, please review TRON's latest 15-C as well.
THERE IS a reverse split announced within the 15-C. As investor's on this board explained, IT'S A RECAPITALIZATION OF THE COMPANY'S STOCK for the APO. I do not recommend reviewing the term "REVERSE SPLIT" as an actual R/S, or as a negative. TRON has announced ample information regarding it's merger and the future of TRON. HOKIEHEAD has made numerous post's explaining how it's a recapitalization.
Again, sticky #9538 explains in detail the Press Release and ample supplemental information regarding TRON's merger.
If any new investor has questions, please feel free to ask anyone on this board. I would like this board to be as healthy and helpful as possible.
------------------------------------------------------------------
Janice Shell
You realize, I hope, that an "APO" is just a reverse merger…
I see you're still citing Clinton Greyling. Why?
------------------------------------------------------------------
To my understanding, a plain "Reverse merger" and an "APO" are two different things. I don't understand why it matters that a particular person is being cited either.
HOKIEHEAD in his post #9628 has explained it well and show's proof of my statement above:
"In a traditional reverse merger, anyone could simply buy a shell and go public whether or not they had sufficient financial performance to justify being a public company. With an APO, the investment bank would not raise capital for a company that it did not believe would be successful in the marketplace. This is why the APO has such a high success rate. The investment bank also brings research, trading and liquidity to the company’s stock after the transaction closes. Investment banks find the APO process appealing because they can receive the same fees and breakage for raising the capital as they do in an IPO in a much condensed period of time and to a significantly smaller number of investors."
There are also other references and on this board that explain what an APO is that doesn't cite "Greyling".
------------------------------------------------------------------
Janice Shell
No. What's "in there" is three stickies about the same press release. There is no mention anywhere of an "investment bank".
------------------------------------------------------------------
Post #9538 (which is also stickied) not only has the merger news, but related DD and supplemental links that elaborate on the merger details. Within the sticky are links that describe what an APO is, and within those links explain how an investment bank is involved. Please refer to post #9628.
Hoping this week jump-starts TRON. A ton of great DD from everyone. Hoping new investors read up and come to the conclusion that TRON has great potential.
Droopy, please explain "Buyer Beware" for us.
I have said in another post that a R/S is usually seen as a negative. IF in fact TRON announced a R/S without any supplemental information, then I would agree. For TRON's case though, it is NOT.
TRON has announced a merger with iMed through an APO (Alternate Public Offering). They have plan's to move higher. Many investor's have posted DD and supplemental DD on TRON's plan merger. For ease of viewing, I have a sticky posted (POST #9538) that consolidates most of it.
HOKIE has also provided many posts stating that it is not a R/S, but in fact a "RECAPITALIZATION" of the stock.
Please research on your own. Don't state "Buyer Beware" because of the phrase "Reverse Split" without doing any DD. We have links and information to prove that TRON as a future.
Awsome thanks
Has anyone tried to get in contact with DOLV in any way? Possibly the CEO?
Thanks Ed!
Did you ask him if this was a real company when you emailed? Or did he randomly state that?
Thank you
Can someone please sticky post #9538? I think it has a lot of good information for current/new investors.
No problem MV, welcome.
TRON MERGER DD
This is a combined TRON MERGER DD post comprised of DD researched and found by investors on this board. SMITTER, HOKIEHEAD, BGALLATIN, MVIR and others, thank you for your contribution and help to everyone.
RECENT PRESS RELEASE: TRON NEWS AUG 19TH 2016
TORON, INC (OTC: TRON) PROVIDES CORPORATE UPDATE REGARDING
PENDING MERGER WITH IMEDSCAN CORPORATION
Toron Inc. to Merge With Disruptive Healthcare Technology Company
MIAMI BEACH, FLORIDA – August 17, 2016 - Toron, Inc (OTC Pink: TRON) provided its stockholders today with a corporate update regarding the pending merger with private company, iMedScan Corporation. Pursuant to the definitive Agreement and Plan of Merger entered into on March 30, 2016 iMedScan will become public through an alternative public offering or “APO” transaction with Toron. On March 21, 2016, in anticipation of the closing of the merger transaction during the third quarter of 2016, Fabrizio Bosticco, the Chief Executive Officer of iMedscan, was also named Chief Executive Officer, President and Director of Toron. iMedican is a healthcare project development and management company holding a proprietary technology that provides for the instant verification of a patient’s medical insurance. “iMedcan’s proprietary technology will generate a twenty-five (25%) reduction in patient insurance rejections or denials from insurance payors,” Bostico said. He continued, “changes in the healthcare industry have considerably lowered profit margins and increase the costs of healthcare to consumers; we believe our technology will create significant cost reductions that will benefit both insurers and insureds.” In March, 2016, iMedScan entered into an agreement with Acuant Corporation of Los Angeles, California to employ its proprietary, hosted scanning solution on patient’s driver’s licenses and insurance cards. Most recently, in June, 2016, iMedScan finalized a test program with Change America, formerly Emdeon Corpoation, utilizing an electronic data interchange for verifying and validating patients’ health insurance. “We estimate a fifty (50%) percent net profit recapture from each medical office that adopts our technology,” Bostico noted. Currently, in addition to traditional medical offices, iMedScan is focusing on the further development and commercialization of kiosk devices hosting the company’s scanning solution.
About Toron, Inc. & iMedScan Corporation On March 30, 2016, Toron, Inc. entered into an definitive Agreement and Plan of Merger with iMedScan corporation, pursuant to which, upon closing, iMedScan will become a wholly-owned subsidiary of Toron. iMedscan Corporation is an innovative disruptive healthcare technology company focused on integrating access to electronic data interfaces (“EDI”) for healthcare providers and payor systems in a user friendly manner. iMedScan’s technology provides ease of use for patients by simplifying their check-in registration process, while at the same time reducing the healthcare providers’ administrative expenses and lost revenues by eliminating insurance rejections, denials or any incorrect results arising from erroneous or incomplete patient information verification. iMedScan’s proprietary iMedScan Connect and iMedScan EDI technologies will combine to create strong, recurring revenue for the company. Statements in this press release that are not historical fact may be deemed forward looking
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Toron, Inc believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Toron is unable to give any assurance
that its expectations will be attained. Factors that could cause actual results to differ materially from expectations include the company’s ability meet the conditions necessary to, among other matters, obtain a public listing on a major national exchange.
###
Contact:
Pacifix Financial, LLC
Tel. (630) 854-7942
at@pacifixfinancial.com
LINK TO IMED WEBSITE
https://imedscan.com/
LINK TO TORON'S FUTURE WEBSITE
http://toroninc.com/
LINK TO ACUANT WEBSITE
http://www.acuantcorp.com/
LINK TO CHANGE HEALTHCARE WEBSITE
http://changehealthcare.com/
SUPPLEMENTAL INFO ON CHANGE HEALTHCARE PR SEP 3RD 2015
http://www.prnewswire.com/news-releases/emdeon-to-rebrand-as-change-healthcare-300137812.html
QUICK TIDBIT ON CHANGE HEALTHCARE'S PR BACK IN SEPTEMBER
The company's Intelligent Healthcare Network is the single largest financial and administrative healthcare network in the United States, reaching approximately 750,000 physicians, 105,000 dentists, 60,000 pharmacies, 5,000 hospitals, 600 vendors, 450 laboratories and 1,200 government and commercial payers, and allows the company to bring actionable data, analytics and insights to the healthcare ecosystem. The company's network processed approximately 8.1 billion healthcare-related transactions, covering $1.2 trillion in claims, in 2014. The company has developed this network of payers and providers over 30 years and connects to virtually all private and government payers, claim-submitting providers and pharmacies in a hybrid cloud-based, user-centric and secure infrastructure environment.
LINKS TO WHAT AN APO IS AND IT'S PROCESS
http://www.slideshare.net/ClintonGreyling/ipo-vs-apo
https://en.wikipedia.org/wiki/Alternative_public_offering
EXAMPLES OF COMPANIES THAT COMPLETED AN APO
Valeritas Holdings, Inc. (OTCQB: VLRX) announced today its successful completion of an alternative public offering (APO). This was accomplished via a reverse merger of its wholly owned operating company, Valeritas, Inc. and a private placement of approximately 5 million shares of its unregistered common stock at $5.00 per share.
http://news.sys-con.com/node/3796621
June 08, 2016
Miramar Labs, Inc. Completes APO, Raises $9.0 Million
https://globenewswire.com/news-release/2016/06/08/846990/0/en/Miramar-Labs-Inc-Completes-Alternative-Public-Offering-Raises-9-0-Million.html
Currently $5
http://www.otcmarkets.com/stock/MRLB/quote
May 04, 2016
Valeritas Completes APO and Raises Gross Proceeds of $25.2 Million
http://www.prnewswire.com/news-releases/valeritas-completes-alternative-public-offering-and-raises-gross-proceeds-of-252-million-578078911.html
Currently $5
http://www.otcmarkets.com/stock/VLRX/quote
Alternative Public Offerings are likely to push more private and successfully crowdfunded businesses into the public markets
http://www.growvc.com/blog/2014/11/how-crowdfunding-will-grease-the-skids-for-alternative-public-offerings/
OTHER EXAMPLES
Miramar Labs, they did an APO, they were trading at $0.51 then they announced the APO that had a $9 million placement for 1.8 million shares. (9/1.8 = $5). The stock traded for $5 and has held above that.
Also look at ONVO, they did an APO, they were trading for pennies on the OTC then announced $6.5 million placement for 22.4 million shares. They opened at $1.65 and hit $10+ in 4 months and now are on Nasdaq.
In 2016 VLRX was trading for pennies under CYGM then announced $25 million placement for 5 million shares at $5 a share. They opened up at $6 and are trading $5-$6. Had you owned the CYGM shares you banked huge.
EKSO did a huge APO,
http://ir.eksobionics.com/press-releases/detail/114/robotic-exoskeleton-innovator-ekso-bionics-goes-public
They opened at $2.50 and hit a high of $8 less than a month later and is now on Nasdaq.
Look at ENUM, good explanation here:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124160410
PARAGRAPH ON TRON'S 15-C STATING A REVERSE SPLIT
1.13 Split of TRON Shares. Immediately prior to the Closing Date, TRON will split the issued and outstanding TRON Shares such that the TRON Shares issued and outstanding immediately prior to the Effective Time shall equal approximately 6% of the total amount of issued and outstanding shares immediately after the Effective Time, calculated on a Fully Diluted Basis or 1,500,000 shares, whichever is greater. For the purposes of this Agreement, the term “Fully Diluted Basis” shall include all issued and outstanding shares of capital stock of TRON and all shares of capital stock issuable upon conversion of all TRON Convertible Securities, but shall exclude all options to purchase any class of capital stock of TRON that have not yet vested as of the Closing Date. Immediately prior to the Effective Time there shall be 745,589,316 TRON Shares issued and outstanding, subject to adjustment as provided above. The calculation of the split of the TRON Shares and the TRON Shares to be issued as Total Merger Consideration is set forth in Exhibit C.
PARAGRAPH ON MERGER CONSIDERATION: CONVERSION OF SHARES
1.4 Merger Consideration; Conversion of Shares. The total consideration to be paid to the Company Shareholders in connection with the Merger (the “Total Merger Consideration”) shall be issuance of up to 25,0000,000 restricted shares on a 25,000 for 1 basis of TRON Common Stock, par value $0.001 per share (the “TRON Shares”), to the Company Shareholders on the Closing Date. Subject to the provisions of this Agreement, at the Effective Time, by virtue of the Merger and without any action on the part of the Company Shareholders, the Company, TRON or the TRON Subsidiary, each outstanding share of Common Stock of the Company shall be converted into the right to receive a pro rata amount of TRON Shares.
Investor's, other than this post, please read the other posts made from this board and conduct your own DD. If you have any questions, myself and everyone here can assist.
I agree.
A lot of great DD has been provided by this board so far, amplifying and adding from the PR that came out Friday.
I am fairly certain TRON will stay healthy and increase in value from here on out.
Investors: Please do your DD! TRON may be a great investment opportunity IMO.
Assuming you have seen situations like this, we still cannot go with opinions with no factual data.
So far HOKIE has presented facts, links and examples of how mergers/APO'S go. TRON so far has not shown any red flags.
TRON filing a form 15 to go dark and hide information from the public? Really? Based on opinion? I HIGHLY doubt that
I'm going for the benefit of the doubt Malc and assume your have been trying to "help" us, but opinions are opinions.
Understood. Good post Hokie.
Also, I recommend reviewing the posts on this board. Myself, HOKIE, SMITTER and many others have posted valuable info here.
DROOPY, I posted this a few hours ago. Please read and decide for yourself.
Also HOKIE, I understand it's a recapitalization, but for the sake of others or new investors I'm going to use the term R/S, since it it stated in the 15c.
___
I agree, investors (including myself) look at reverse splits as a negative, but there ARE good reasons for doing one.
As SMITTER said, they are trying to clean their books. The R/S may not happen, but if it does, it's solely on getting the merger and APO process complete.
If they were to just announce a R/S with no supplemental information, then I would agree that it would be a negative. In this case, I do not believe so.
But as I said, some of this is my opinion. Trust your gut and make the decision you belive is right.
Agreed.
I agree, investors (including myself) look at reverse splits as a negative, but there ARE good reasons for doing one.
As SMITTER said, they are trying to clean their books. The R/S may not happen, but if it does, it's solely on getting the merger and APO process complete.
If they were to just announce a R/S with no supplemental information, then I would agree that it would be a negative. In this case, I do not believe so.
But as I said, some of this is my opinion. Trust your gut and make the decision you belive is right.
This is the only thing I think contradicts this theory.
For the APO process, the private company takes over the shell company, and in the end the private company is all that remains.
You are correct that the PR states that iMed will become a subsidiary of TRON, so I am unsure.
Could I be incorrect?
By all means, I hope you are right about a possible second merger.
Some of this is my opinion, so please keep that in mind.
TRON's CEO is the same as HMNU, which ran from sub-penny/single penny to .30 within 1-2 months. Investors were hoping to follow that same path with TRON.
TRON released info stating that there will be a 1:500 reverse split, which shook investor confidence and the share price fell.
TRON released a PR yesterday stating that they will be merging with iMed, and that an APO will be completed possibly NLT September 30th.
TRON probably required to conduct a R/S for the merger and APO process.
I have provided posts in regards to what the APO process is and why they elected to do a R/S, which IMO is for a very good reason.
SMITTER has also provided very useful posts and insight on TRON, along with many other investors here. I recommend taking the time to review their posts, while also continuing your DD.
I think this has great potential.
Let's hope that is the case!
Very good. Looking forward to TRON's future.
Smitter, I'm hoping your right about a possible finance merger in the future. If there is going to be one, and if it's on the same caliber as this iMed merger or better.....jesus.
Let's just say I'm not trying to get my hopes up lol ??
During the APO process, it typically requires reorganization of capitalization of the acquiring company (For this case, iMed acquiring TRON).
TRON and iMed is IN FACT, doing an APO.
TRON probably needed to do a R/S to get ready for the pending merger and APO.
This is to possibly answer the question of why TRON Is doing a R/S. From what it seems like, it's for a VERY good cause.
IMO, TRON and iMed isn't planning to screw shareholders. They are doing what they need to do to merge and complete the APO process.
For those who are still not familiar with the APO (Alternative Public Offering) process, there are link is below. Other info can be found online.
http://www.slideshare.net/ClintonGreyling/ipo-vs-apo
https://en.wikipedia.org/wiki/Alternative_public_offering
Please do your DD. This is my opinion only, but I believe this is a solid deal. Don't let other posters opinion (either good or bad) influence how you handle YOUR investment with TRON. But TBH, I highly recommend looking into this.
Is there anyone that can sticky the latest merger news and a link to the description of an APO?
I hope so. So far things are looking good. If they hit us with another merger things can get very hectic on the plus side.
Good stuff!
I HIGHLY recommend everyone read the full description of the APO process. LOTS of good information. It also may shed some light on why/how TRON is setting themselves up the way they are.
It also states that the private company (iMed) pay's for the shell company (TRON) by contributing their shares from the private company to the shell company that they now control.
They also have a finance option where they can issue additional stock after the APO is compete. Possible forward split afterwards? Just my opinion.
For those who are not familiar with the APO (Alternative Public Offering) process and benefits.
http://www.slideshare.net/ClintonGreyling/ipo-vs-apo
Can someone sticky the latest merger news?
Q2 today possibly?
What's the deal with this stock? I know they de-listed from NASDAQ and their last reported news was both in 2004. Why/how is this stock still trading? I haven't found any, but has their been any news/emails/PR's since? Anything at all in regards to forward progress for this stock?